Hermes Medical Solutions Inc.

Hermes Medical Solutions Inc., a foreign-owned small business based in Farmville, North Carolina, supplies nuclear medicine imaging systems, medical equipment, imaging software, and maintenance services to the Department of Defense and the federal healthcare enterprise as a 100% prime contractor with no subcontract footprint.

The company holds three major indefinite delivery contracts with the Defense Logistics Agency and Defense Health Agency totaling $152 million through December 2033: a $100 million single-award IDC for medical capital equipment and services (awarded October 2023), a $50 million single-award electronic catalog contract for medical equipment procurement (awarded November 2024), and a GSA Federal Supply Schedule contract with a $2 million ceiling (awarded April 2024). The IDCs establish Hermes as a strategic vendor for deliverables including advanced nuclear medicine imaging technology, examination tables and hospital beds, laboratory analyzers, dental equipment, IT software licensing, clinical and administrator training, installation services, and comprehensive maintenance support. Recent delivery orders under these vehicles include a $131,398.80 annual maintenance and subscription order from the Defense Health Agency (April 2026), a $68,640 order for a Cedars Sinai Deluxe Perfusion SPECT system (April 2026), and a $133,000 order for INVIA Cardiology SPECT and PET imaging systems (September 2025).

Customer concentration is extreme. The Defense Logistics Agency Troop Support Medical dominates with 34 awards and $151.3 million in combined potential value — 89% of total pipeline. The Defense Health Agency contributes 17 awards ($3.1 million), and the Department of the Army Medical Command adds 13 awards ($11.6 million). These three customers account for 93% of recent awards by count and essentially 100% by potential value. The portfolio breadth is narrow: 36 of 74 awards fall under Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (NAICS 424210), with 35 awards coded to Imaging Equipment and Supplies—Medical, Dental, Veterinary (PSC 6540). Software and maintenance work rounds out the mix through secondary NAICS and PSC categories.

Activity has accelerated sharply. The company recorded one award in 2023, four in 2024, and 28 in 2025 — a 600% jump year over year. The 2026 pace (four awards in the first quarter) continues the trajectory. However, recompete exposure is minimal: only one award ($500 thousand) reaches ultimate completion within the next 24 months, with the bulk of the $152 million IDC base running through December 2033. The company competes entirely in full-and-open procurement; no awards carry small business set-aside designations, though one historical FDA purchase order (June 2022, $17,600) was set aside for total small business.

Hermes Medical Solutions registered in SAM.gov in 2003 and maintains its point of production in Greenville and Farmville, North Carolina. It is a subsidiary of Hermes Medical Solutions LIMITED, a foreign-owned parent organization also registered to receive federal awards. The vendor's federal market position is entirely dependent on the DLA and DHA relationships — loss of either the $100 million or $50 million IDC in a recompete would represent existential recompete risk, though neither vehicle faces recompete before 2033. The company does not appear as a subcontractor in the source material and operates no teaming relationships visible from the award footprint.

Hermes Medical Solutions specializes in advanced imaging software and clinical applications for PET, SPECT, CT, Theranostics, Dosimetry, and MRI, enhancing diagnostic accuracy and clinical outcomes in nuclear medicine and molecular imaging. Our molecular imaging software takes nuclear medicine to a new level. Experience the benefits of a single vendor-neutral system - with all the tools you need for your molecular imaging/nuclear medicine work in ONE place.